Literature DB >> 14567469

Homocysteine inhibits butyrylcholinesterase activity in rat serum.

Francieli M Stefanello1, Alexandra I Zugno, Clovis M D Wannmacher, Moacir Wajner, Angela T S Wyse.   

Abstract

In the present work we investigated the in vitro effects of homocysteine (Hcy) and methionine (Met), metabolites accumulated in homocystinuria, on butyrylcholinesterase (BuChE) activity in rat serum. We also studied the kinetics of the inhibition of BuChE activity caused by Hcy. For determination of BuChE we used serum of 60-day-old Wistar rats, which was incubated in the absence (control) or presence of Hcy (0.01-0.5 mM) or Met (0.2-2.0 mM). The kinetics of the interaction of Hcy and BuChE was determined using the Lineweaver-Burk double reciprocal plot. Results showed that serum BuChE activity was not altered by Met, but it was significantly inhibited (37%) by 500 microM Hcy, a concentration similar to those found in blood of homocystinuric patients. The apparent Km values, in the absence and presence of 500 microM of Hcy, were 0.034 and 0.142 mM, respectively, and V(max) of BuChE for acetylcholine (ACh) as substrate was 1.25 micromol ACSCh/h/mg of protein. The Ki value obtained was 120 microM, and the inhibition was of the competitive type, suggesting a common binding site for Hcy and ACh. It is proposed that inhibition of cholinesterase activity may be one of the mechanisms involved in the neurological dysfunction observed in homocystinuria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567469     DOI: 10.1023/a:1025551031767

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  37 in total

1.  Non-specific cholinesterase activity of the developing peripheral nerves and its possible function in cells in intimate contact with growing axons of chick embryo.

Authors:  P Dubovy; P Haninec
Journal:  Int J Dev Neurosci       Date:  1990       Impact factor: 2.457

2.  Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

Authors:  H Tohgi; T Abe; M Kimura; M Saheki; S Takahashi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?

Authors:  E Giacobini
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study.

Authors:  A Mack; A Robitzki
Journal:  Prog Neurobiol       Date:  2000-04       Impact factor: 11.685

Review 5.  Folic acid and homocysteine in age-related disease.

Authors:  Mark P Mattson; Inna I Kruman; Wenzhen Duan
Journal:  Ageing Res Rev       Date:  2002-02       Impact factor: 10.895

6.  Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients.

Authors:  P Gómez-Ramos; M A Morán
Journal:  Mol Chem Neuropathol       Date:  1997-04

Review 7.  Homocysteine as a risk factor for atherosclerosis.

Authors:  M E Temple; A B Luzier; D J Kazierad
Journal:  Ann Pharmacother       Date:  2000-01       Impact factor: 3.154

8.  Pretreatment with vitamins E and C prevent the impairment of memory caused by homocysteine administration in rats.

Authors:  Eleonora A Reis; Alexandra I Zugno; Renata Franzon; Bárbara Tagliari; Cristiane Matté; Marcelo L Lammers; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

9.  Inhibition of Na+, K+-ATPase activity by the metabolites accumulating in homocystinuria.

Authors:  Emilio L Streck; Alexandra I Zugno; Barbara Tagliari; Clovis Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2002-06       Impact factor: 3.584

10.  Seizures induced by homocysteine in rats during ontogenesis.

Authors:  H Kubová; J Folbergrová; P Mares
Journal:  Epilepsia       Date:  1995-08       Impact factor: 5.864

View more
  5 in total

1.  Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.

Authors:  Francieli M Stefanello; Renata Franzon; Bárbara Tagliari; Clovis Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

2.  Homocysteine thiolactone and human cholinesterases.

Authors:  Sultan Darvesh; Ryan Walsh; Earl Martin
Journal:  Cell Mol Neurobiol       Date:  2006-09-06       Impact factor: 5.046

3.  Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance.

Authors:  Camila Simioni Vanzin; Caroline Paula Mescka; Bruna Donida; Tatiane Grazieli Hammerschimidt; Graziela S Ribas; Janaína Kolling; Emilene B Scherer; Laura Vilarinho; Célia Nogueira; Adriana Simon Coitinho; Moacir Wajner; Angela T S Wyse; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2015-03-25       Impact factor: 5.046

4.  Hyperhomocysteinemia induced by methionine dietary nutritional overload modulates acetylcholinesterase activity in the rat brain.

Authors:  Dragan Hrnčić; Aleksandra Rašić-Marković; Tihomir Stojković; Milica Velimirović; Nela Puškaš; Radmila Obrenović; Djuro Macut; Veselinka Sušić; Vladimir Jakovljević; Dragan Djuric; Nataša Petronijević; Olivera Stanojlović
Journal:  Mol Cell Biochem       Date:  2014-07-23       Impact factor: 3.396

5.  In vitro homocysteine inhibits platelet Na+,K+-ATPase and serum butyrylcholinesterase activities of young rats.

Authors:  Francieli M Stefanello; Renata Franzon; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-12       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.